🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a randomized, double-blinded, and placebo-controlled phase Ia...
Status
Completed
Location
West China Second University Hospital, Sichuan University / West China women's and children's Hospital
Start Date
2020-05-15
Trial ID
NCT04412538
Treatments Being Tested
This pilot randomized, double-blind, placebo-controlled study evaluates the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT06877377
Treatments Being Tested
This is a Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Cen...
Status
Terminated
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2017-05-14
Trial ID
NCT02737306
The proposed project is focused towards evaluation of Pirfenidone as a nove...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT07755813
This is a two-part multi-center clinical trial in participants with active ...
Status
Terminated
Location
Emory Healthcare
Start Date
2021-10-13
Trial ID
NCT04918147
This study is a randomized, double-blinded, and placebo controlled phase Ⅱ ...
Status
Unknown
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2020-10-27
Trial ID
NCT04756323
An imbalance in the gut microbiota and mucosal immune dysfunction leading t...
Status
Recruiting
Location
The Seventh Medical Center, PLA General Hospital
Start Date
2024-09-21
Trial ID
NCT06609447
Treatments Being Tested
This study is a prospective, multi-center, randomized, double blinded, plac...
Status
Recruiting
Location
Yale School of Medicine
Start Date
2023-02-07
Trial ID
NCT05285891
Treatments Being Tested
Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp R...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2021-07-21
Trial ID
NCT04959500
Treatments Being Tested
BCD-085 is an innovative drug, a monoclonal antibody against interleukin-17...
Status
Completed
Location
BIOCAD
Start Date
2017-12-26
Trial ID
NCT03390101
Treatments Being Tested